These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15199733)

  • 1. [A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia].
    Onoue H; Matsunobu A; Nagaishi A; Yukitake M; Kuroda Y
    Rinsho Shinkeigaku; 2004 Jan; 44(1):20-4. PubMed ID: 15199733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuromuscular blockade with botulinum toxin. From toxin to therapeutic agent].
    Einecke D
    MMW Fortschr Med; 2001 May; 143 Suppl 2():95-6. PubMed ID: 11434276
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin for cervical dystonia.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):63-4. PubMed ID: 11468603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aspects of the complexity of cervical dystonia].
    Hefter H
    Nervenarzt; 2008 Jun; 79 Suppl 1():15-8. PubMed ID: 18927959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA; Molho ES; Evans S; Feustel PJ
    Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peri-operative treatment with botulinum A toxin prior to posterior cervical decompression in a case with cervical spondylosis caused by spasmodic torticollis secondary to cerebral palsy].
    Iwamuro H; Takahashi H; Ide K; Nakauchi J; Taniguchi M
    No Shinkei Geka; 2003 Sep; 31(9):1015-20. PubMed ID: 14513786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A.
    Papadonikolakis AS; Vekris MD; Kostas JP; Korompilias AV; Soucacos PN
    J South Orthop Assoc; 2002; 11(2):116-8. PubMed ID: 12741592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia.
    Burguera JA; Villaroya T; López-Alemany M
    Clin Neuropharmacol; 2000; 23(4):226-8. PubMed ID: 11020130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A therapy during pregnancy.
    Newman WJ; Davis TL; Padaliya BB; Covington CD; Gill CE; Abramovitch AI; Charles PD
    Mov Disord; 2004 Nov; 19(11):1384-5. PubMed ID: 15389988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuralgic amyotrophy following botulinum toxin injection.
    Alcalay RN; Simões RM; Feigin A; Frucht S
    Parkinsonism Relat Disord; 2010 May; 16(4):301-2. PubMed ID: 19815448
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical radiculopathy following botulinum toxin therapy for cervical dystonia.
    Defazio G; Lepore V; Melpignano C; Lamberti P; Livrea P; Ferrari E
    Funct Neurol; 1993; 8(3):193-6. PubMed ID: 8406138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia.
    Nebe A; Schelosky L; Wissel J; Ebersbach G; Scholz U; Poewe W
    Mov Disord; 1996 May; 11(3):337-9. PubMed ID: 8723158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection.
    LeWitt PA; Trosch RM
    Mov Disord; 1997 Nov; 12(6):1064-7. PubMed ID: 9399239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.